Amylyx Pharmaceuticals (AMLX) Inventory Average (2022 - 2023)
Amylyx Pharmaceuticals (AMLX) recorded quarterly Inventory Average of $35.3 million in Q4 2023, up 23.53% quarter-over-quarter from $28.6 million in Q3 2023, and up 584.25% on a YoY basis from $5.2 million in Q4 2022.
Amylyx Pharmaceuticals (AMLX) Inventory Average (2022 - 2023) Analysis & Trends
Amylyx Pharmaceuticals' Inventory Average history runs 2 years deep, the most recent figure standing at $35.3 million for Q4 2023.
- In Q4 2023, Inventory Average rose 584.25% year-over-year to $35.3 million; the TTM figure through Dec 2023 stood at $35.3 million (up 584.25% YoY), while the FY2023 annual figure was $24.0 million, changed N/A from the prior year.
- Inventory Average was $35.3 million for Q4 2023 at Amylyx Pharmaceuticals, up from $28.6 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $35.3 million in Q4 2023 to a low of $5.2 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.51 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 180.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 131.60 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 66.75 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.73 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 266.66 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 79.60 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 63.01 Mn |
| 10 | Amylyx Pharmaceuticals | 1.51 Bn | 1.51 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 35.35 Mn |
| Sep 30, 2023 | 28.62 Mn |
| Jun 30, 2023 | 18.97 Mn |
| Mar 31, 2023 | 11.42 Mn |
| Dec 31, 2022 | 5.17 Mn |